Table of Contents Author Guidelines Submit a Manuscript
Review Article
Cardiology Research and Practice
Volume 2011, Article ID 429537, 2 pages
http://dx.doi.org/10.4061/2011/429537
Letter to the Editor

Antioxidant Therapy for Atrial Fibrillation: What Is the Next Step?

Section of Cardiology, Center for Cardiovascular Research, University of Illinois at Chicago, 840 S. Wood Street, MC 715, Chicago, IL 60612, USA

Received 8 September 2011; Accepted 22 September 2011

Copyright © 2011 Ali A. Sovari. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Rasoli, N. Kakouros, L. Harling et al., “Antioxidant vitamins in the prevention of atrial fibrillation: what is the evidence?” Cardiology Research and Practice, vol. 2011, Article ID 164078, 8 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
  2. N. Biary, C. Xie, J. Kauffman, and F. G. Akar, “Biophysical properties and functional consequences of ROS-induced ROS-release in intact myocardium,” The Journal of Physiology, vol. 589, no. 21, pp. 5167–5179, 2011. View at Publisher · View at Google Scholar · View at PubMed
  3. S. N. Reilly, R. Jayaram, K. Nahar et al., “Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins,” Circulation, vol. 124, no. 10, pp. 1107–1117, 2011. View at Publisher · View at Google Scholar · View at PubMed
  4. A. A. Sovari, N. Morita, and H. S. Karagueuzian, “Apocynin: a potent NADPH oxidase inhibitor for the management of atrial fibrillation,” Redox Report, vol. 13, no. 6, pp. 242–245, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. B. O'Rourke, S. Cortassa, and M. A. Aon, “Mitochondrial ion channels: gatekeepers of life and death,” Physiology, vol. 20, no. 5, pp. 303–315, 2005. View at Google Scholar · View at Scopus
  6. A. A. Sovari, S. Iravanian, D. Mitchell et al., “Mitochondria-targeted antioxidant Mito-TEMPO prevents angiotensin II mediated connexin 43 remodeling and sudden cardiac death,” Journal Of Investigative Medicine, vol. 59, no. 4, pp. 692–730, 2011. View at Google Scholar